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Sepsis is notably associated with neuronal damage, an
effect that may be exacerbated by hypoxaemia. The
present study was designed to investigate if this interrela-
tionship involves an effect on brain-derived neurotrophic
factor (BDNF), an intrinsic neuroprotective agent which is
released from the brain under normophysiological condi-
tions [1]. We hypothesised that experimental systemic
inflammation and hypoxaemia would abolish this
release.
36 healthy male volunteers aged 25 (SD, 4) years were
randomised to:
1. normoxia for 12 hours and a four-hour intravenous
infusion of lipopolysaccharide (LPS) from 4–8 h
(total dose 0.3 ng/kg), N = 12
2. hypoxia for 12 hours (12.9% O2) and a four-hour
intravenous infusion of saline from 4–8 h, N = 11
3. hypoxia for 12 hours (12.9% O2) and a four-hour
intravenous infusion of LPS from 4–8 h (total dose of
0.3 ng/kg), N = 13
Cerebral blood flow (CBF) was measured by the Kety-
Schmidt technique, and arterio-jugular venous concentra-
tions of BDNF were determined at baseline and 9 h. The
cerebral net exchange was calculated by multiplying CBF
with the arterio-jugular concentration differences of
BDNF.
A cerebral release of BDNF was present at baseline (P <
0.005). This was attenuated in all three groups, but with
no difference in the cerebral net exchange values from
baseline or between interventions (NS, MANOVA). There
was no effect of any of the interventions on the arterial
levels of BDNF (NS, MANOVA).
In conclusion, systemic inflammation and hypoxaemia
may abolish the net cerebral release of BDNF in healthy
humans.
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